Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
2,084 rows where surface_class = "B_cargo" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P14136 | GFAP | Glial fibrillary acidic protein | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 80.0 | 0 | 0 | 1 | 4 | 42022738, 40983220, 27924617, 27399849 | 1 | Alexander disease | 0.8713727112153956 | ||
| P15848 | ARSB | Arylsulfatase B | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 93.12 | 0 | 0 | 0 | 0 | 1 | mucopolysaccharidosis type 6 | 0.8708405439406184 | |||
| P54802 | NAGLU | Alpha-N-acetylglucosaminidase | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 96.75 | 0 | 0 | 0 | 0 | 1 | mucopolysaccharidosis type 3B | 0.8688752515463204 | |||
| P00480 | OTC | Ornithine transcarbamylase, mitochondrial | Tier 1.5 | 0.76 | 1 | B_cargo | 4 | 92.19 | 0 | 0 | 1 | 71 | 42031033, 41819402, 41207276, 41033028, 40970979, 40801924, 40719766, 40644866, 40602786, 40187287, 40064103, 40015047, 39904249, 39644528, 39571486, 39275399, 39030014, 38504447, 38193253, 37459789, 37364386, 37103619, 36891736, 36618689, 36454704, 36403375, 35884270, 35672499, 35006795, 34973550, 34821674, 34684942, 34152736, 33812186, 33035887, 32862845, 32768827, 32674777, 31673790, 31580049, 31325751, 31016392, 30837641, 30778448, 30594079, 30426224, 30202432, 30128033, 29937498, 28578167 | 1 | ornithine carbamoyltransferase deficiency | 0.8675763935672858 | ||
| P49748 | ACADVL | Very long-chain acyl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.76 | 1 | B_cargo | 3 | 90.25 | 0 | 0 | 0 | 0 | 1 | very long chain acyl-CoA dehydrogenase deficiency | 0.8655785842544526 | |||
| P11532 | DMD | Dystrophin | Tier 1.5 | 0.76 | 1 | B_cargo | 6 | 76.38 | 0 | 0 | 1 | 32 | 41983899, 41503480, 41083485, 40396427, 39910928, 39469668, 38050701, 37765072, 37261868, 34876524, 34693888, 34440571, 34075115, 33617542, 32592467, 28315675, 28252048, 27530235, 27173731, 26594036, 26163061, 26039989, 21838691, 20962041, 17011811, 38448545 | 1 | Duchenne muscular dystrophy | 0.865885140119287 | ||
| Q01968 | OCRL | Inositol polyphosphate 5-phosphatase OCRL | Tier 1.5 | 0.759 | 1 | B_cargo | 5 | 82.56 | 0 | 0 | 0 | 0 | 1 | oculocerebrorenal syndrome | 0.8639646099557533 | |||
| P68133 | ACTA1 | Actin, alpha skeletal muscle | Tier 1.5 | 0.758 | 1 | B_cargo | 5 | 95.12 | 1 | 0 | 0 | 0 | 1 | congenital myopathy 2a, typical, autosomal dominant | 0.8588441418736817 | |||
| P05165 | PCCA | Propionyl-CoA carboxylase alpha chain, mitochondrial | Tier 1.5 | 0.756 | 1 | B_cargo | 25 | 87.44 | 1 | 0 | 1 | 1 | 36578103 | 1 | propionic acidemia | 0.8530542602972598 | ||
| P30566 | ADSL | Adenylosuccinate lyase | Tier 1.5 | 0.756 | 1 | B_cargo | 4 | 96.56 | 0 | 0 | 0 | 0 | 1 | adenylosuccinate lyase deficiency | 0.8537075354730899 | |||
| P35914 | HMGCL | Hydroxymethylglutaryl-CoA lyase, mitochondrial | Tier 1.5 | 0.755 | 1 | B_cargo | 4 | 92.0 | 0 | 0 | 0 | 0 | 1 | 3-hydroxy-3-methylglutaric aciduria | 0.84972741897364 | |||
| P51648 | ALDH3A2 | Aldehyde dehydrogenase family 3 member A2 | Tier 1.5 | 0.755 | 1 | B_cargo | 1 | 96.62 | 0 | 0 | 0 | 0 | 1 | Sjögren-Larsson syndrome | 0.8498976178886021 | |||
| Q14896 | MYBPC3 | Myosin-binding protein C, cardiac-type | Tier 1.5 | 0.755 | 1 | B_cargo | 17 | 78.81 | 1 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy | 0.8502637105703099 | |||
| P30084 | ECHS1 | Enoyl-CoA hydratase, mitochondrial | Tier 1.5 | 0.755 | 1 | B_cargo | 6 | 91.69 | 1 | 0 | 0 | 0 | 1 | mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency | 0.8483381531913922 | |||
| P35475 | IDUA | Alpha-L-iduronidase | Tier 1.5 | 0.755 | 1 | B_cargo | 11 | 94.75 | 0 | 0 | 1 | 1 | 18838694 | 1 | Scheie syndrome | 0.8500187612858606 | ||
| P50336 | PPOX | Protoporphyrinogen oxidase | Tier 1.5 | 0.755 | 1 | B_cargo | 3 | 95.31 | 0 | 0 | 0 | 0 | 1 | variegate porphyria | 0.8511493920751063 | |||
| P26440 | IVD | Isovaleryl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.754 | 1 | B_cargo | 5 | 93.38 | 1 | 0 | 1 | 2 | 41230502, 26946282 | 1 | isovaleric acidemia | 0.8480603595890895 | ||
| P48637 | GSS | Glutathione synthetase | Tier 1.5 | 0.754 | 1 | B_cargo | 2 | 94.94 | 0 | 0 | 1 | 1 | 24296062 | 1 | Glutathione synthetase deficiency | 0.8480115629745476 | ||
| P36871 | PGM1 | Phosphoglucomutase-1 | Tier 1.5 | 0.753 | 1 | B_cargo | 16 | 97.12 | 0 | 0 | 0 | 0 | 1 | PGM1-congenital disorder of glycosylation | 0.843931261346685 | |||
| O95571 | ETHE1 | Persulfide dioxygenase ETHE1, mitochondrial | Tier 1.5 | 0.752 | 1 | B_cargo | 1 | 92.88 | 0 | 0 | 0 | 0 | 1 | ethylmalonic encephalopathy | 0.8389957647020829 | |||
| P50897 | PPT1 | Palmitoyl-protein thioesterase 1 | Tier 1.5 | 0.752 | 1 | B_cargo | 1 | 91.69 | 0 | 0 | 1 | 2 | 33112630 | 1 | neuronal ceroid lipofuscinosis 1 | 0.8400332147230634 | ||
| P50416 | CPT1A | Carnitine O-palmitoyltransferase 1, liver isoform | Tier 1.5 | 0.751 | 1 | B_cargo | 1 | 92.44 | 0 | 0 | 1 | 1 | 29325019 | 1 | carnitine palmitoyl transferase 1A deficiency | 0.8360102017303558 | ||
| P35573 | AGL | Glycogen debranching enzyme | Tier 1.5 | 0.75 | 1 | B_cargo | 1 | 92.75 | 1 | 0 | 0 | 0 | 1 | glycogen storage disease III | 0.8321686508777297 | |||
| Q9Y4W6 | AFG3L2 | Mitochondrial inner membrane m-AAA protease component AFG3L2 | Tier 1.5 | 0.75 | 1 | B_cargo | 2 | 76.75 | 1 | 0 | 0 | 0 | 1 | spinocerebellar ataxia type 28 | 0.8341800061294613 | |||
| P54886 | ALDH18A1 | Delta-1-pyrroline-5-carboxylate synthase | Tier 1.5 | 0.75 | 1 | B_cargo | 1 | 84.19 | 0 | 0 | 0 | 0 | 1 | ALDH18A1-related de Barsy syndrome | 0.8337004817329543 | |||
| P48728 | AMT | Aminomethyltransferase, mitochondrial | Tier 1.5 | 0.749 | 1 | B_cargo | 2 | 93.69 | 0 | 0 | 1 | 6 | 41360349, 38751431, 36935143, 32969502, 32779681, 32062632 | 1 | glycine encephalopathy | 0.8307194416875259 | ||
| Q9H0F7 | ARL6 | ADP-ribosylation factor-like protein 6 | Tier 1.5 | 0.749 | 1 | B_cargo | 1 | 94.69 | 0 | 0 | 0 | 0 | 1 | Bardet-Biedl syndrome | 0.831055560105815 | |||
| P02538 | KRT6A | Keratin, type II cytoskeletal 6A | Tier 1.5 | 0.748 | 1 | B_cargo | 1 | 66.31 | 0 | 0 | 0 | 0 | 1 | pachyonychia congenita | 0.8265917804295808 | |||
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | Tier 1.5 | 0.748 | 1 | B_cargo | 2 | 86.56 | 1 | 0 | 1 | 1 | 23770039 | 1 | abetalipoproteinemia | 0.8281089516017405 | ||
| P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | Tier 1.5 | 0.748 | 1 | B_cargo | 1 | 91.94 | 0 | 0 | 0 | 0 | 1 | succinyl-CoA:3-ketoacid CoA transferase deficiency | 0.8271377770408165 | |||
| Q8IWV7 | UBR1 | E3 ubiquitin-protein ligase UBR1 | Tier 1.5 | 0.748 | 1 | B_cargo | 5 | 84.69 | 0 | 0 | 0 | 0 | 1 | Johanson-Blizzard syndrome | 0.8277473176517505 | |||
| Q9Y484 | WDR45 | WD repeat domain phosphoinositide-interacting protein 4 | Tier 1.5 | 0.747 | 1 | B_cargo | 3 | 90.5 | 1 | 0 | 0 | 0 | 1 | neurodegeneration with brain iron accumulation 5 | 0.8230559793277397 | |||
| P12955 | PEPD | Xaa-Pro dipeptidase | Tier 1.5 | 0.747 | 1 | B_cargo | 21 | 97.44 | 0 | 0 | 0 | 0 | 1 | prolidase deficiency | 0.8227965856258603 | |||
| Q15833 | STXBP2 | Syntaxin-binding protein 2 | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 90.0 | 0 | 0 | 0 | 0 | 1 | Familial hemophagocytic lymphohistiocytosis | 0.8239664182555839 | |||
| Q53H12 | AGK | Acylglycerol kinase, mitochondrial | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 87.0 | 1 | 0 | 1 | 1 | 35763566 | 1 | Sengers syndrome | 0.8231275438888749 | ||
| Q14739 | LBR | Delta(14)-sterol reductase LBR | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 76.62 | 0 | 0 | 0 | 0 | 1 | Greenberg dysplasia | 0.8198252534620432 | |||
| O75027 | ABCB7 | Iron-sulfur clusters transporter ABCB7, mitochondrial | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 78.12 | 1 | 0 | 0 | 0 | 1 | X-linked sideroblastic anemia with ataxia | 0.821045506234113 | |||
| P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 91.69 | 0 | 0 | 0 | 0 | 1 | glycogen storage disease VII | 0.8199812991737021 | |||
| P38571 | LIPA | Lysosomal acid lipase/cholesteryl ester hydrolase | Tier 1.5 | 0.745 | 1 | B_cargo | 1 | 91.56 | 0 | 0 | 0 | 0 | 1 | cholesteryl ester storage disease | 0.8176913717992665 | |||
| Q14938 | NFIX | Nuclear factor 1 X-type | Tier 1.5 | 0.745 | 1 | B_cargo | 3 | 61.62 | 0 | 0 | 0 | 0 | 1 | Malan overgrowth syndrome | 0.8156080181042044 | |||
| P02549 | SPTA1 | Spectrin alpha chain, erythrocytic 1 | Tier 1.5 | 0.745 | 1 | B_cargo | 3 | 76.38 | 0 | 0 | 0 | 0 | 1 | elliptocytosis 2 | 0.8153311905916062 | |||
| P63267 | ACTG2 | Actin, gamma-enteric smooth muscle | Tier 1.5 | 0.745 | 1 | B_cargo | 4 | 95.38 | 1 | 0 | 0 | 0 | 1 | visceral myopathy 1 | 0.8175814609874555 | |||
| P04080 | CSTB | Cystatin-B | Tier 1.5 | 0.744 | 1 | B_cargo | 3 | 95.56 | 0 | 0 | 0 | 0 | 1 | Unverricht-Lundborg disease | 0.8143874694671263 | |||
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Tier 1.5 | 0.744 | 1 | B_cargo | 10 | 87.25 | 1 | 0 | 1 | 5 | 41290466, 38569854, 31879964, 31702021, 21433395 | 1 | Chronic mucocutaneous candidosis | 0.8147374964880533 | ||
| Q15738 | NSDHL | Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating | Tier 1.5 | 0.744 | 1 | B_cargo | 2 | 88.62 | 0 | 0 | 0 | 0 | 1 | CHILD syndrome | 0.81209434191833 | |||
| O95822 | MLYCD | Malonyl-CoA decarboxylase, mitochondrial | Tier 1.5 | 0.744 | 1 | B_cargo | 2 | 89.94 | 0 | 0 | 0 | 0 | 1 | malonic aciduria | 0.8148554714603661 | |||
| P51159 | RAB27A | Ras-related protein Rab-27A | Tier 1.5 | 0.744 | 1 | B_cargo | 11 | 83.94 | 1 | 0 | 0 | 0 | 1 | Griscelli syndrome type 2 | 0.8139882966122653 | |||
| Q01433 | AMPD2 | AMP deaminase 2 | Tier 1.5 | 0.744 | 1 | B_cargo | 4 | 80.69 | 0 | 0 | 0 | 0 | 1 | pontocerebellar hypoplasia type 9 | 0.8149450703818453 | |||
| Q14839 | CHD4 | ATP-dependent chromatin remodeler CHD4 | Tier 1.5 | 0.743 | 1 | B_cargo | 12 | 64.62 | 1 | 0 | 0 | 0 | 1 | Sifrim-Hitz-Weiss syndrome | 0.8103430577478806 | |||
| Q8TCS8 | PNPT1 | Polyribonucleotide nucleotidyltransferase 1, mitochondrial | Tier 1.5 | 0.743 | 1 | B_cargo | 11 | 87.44 | 1 | 0 | 0 | 0 | 1 | combined oxidative phosphorylation defect type 13 | 0.8091107966912156 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;